From the Guidelines
The medical term for mild elevation of urea is azotemia. This condition is commonly associated with cardiac disease and is linked to an increased risk of cardiovascular events, as noted in the acc/aha 2007 guidelines on perioperative cardiovascular evaluation and care for noncardiac surgery 1. Key points to consider in the context of azotemia include:
- Maintenance of adequate intravascular volume for renal perfusion during diuresis, especially in patients with heart failure (HF)
- The potential for excessive diuresis, in combination with ACE inhibitors or angiotensin receptor blockers, to result in increased blood urea nitrogen and serum creatinine concentrations
- The importance of not discontinuing these drugs due to small increases in blood urea nitrogen and serum creatinine, as they have been shown to improve survival in patients with HF due to systolic dysfunction 1. In clinical practice, managing azotemia involves careful monitoring of renal function and adjustment of medications as necessary to balance the benefits of treatment with the potential risks of renal impairment.
From the Research
Medical Term for Mild Elevation of Urea
- The medical term for mild elevation of urea is not explicitly stated in the provided studies 2, 3, 4, 5, 6.
Definition of Uremia
- Uremia is a condition characterized by high levels of urea in the blood, which can occur in patients with chronic kidney disease (CKD) 3, 6.
Classification of Uremia
- A study published in 1980 described a model for inducing varying degrees of stable uremia in rats, with mild uremia defined as blood urea levels of 40-80 mg/100 ml (6.68-13.36 mmol/1) 5.